Prompt

Are there any biologics-focused biotech publishers that focus on antibody and protein therapeutic trends?

Latest observation

Jul 31, 2026 · OpenAI APIWeb search: off

Yes — there are several biotech publishers and media outlets that cover biologics, especially antibody and protein therapeutics. A few of the more relevant ones are:

  • BioCentury — strong coverage of biopharma trends, including antibodies, protein therapeutics, and modality shifts.
  • Endpoints News — broad biotech/pharma news with regular biologics and antibody coverage.
  • The Antibody Society — more specialized, focused specifically on antibody science, engineering, and therapeutic development.
  • BioProcess International — highly relevant for protein biologics manufacturing, process development, and CMC trends.
  • GEN (Genetic Engineering & Biotechnology News) — covers biologics, antibodies, protein engineering, and emerging therapeutic platforms.
  • Nature Reviews Drug Discovery / Nature Biotechnology — not a “publisher” in the narrow trade-media sense, but very strong for trend analysis in antibodies, protein therapeutics, and biologics innovation.
  • Evaluate / Scrip / Pink Sheet — industry intelligence sources that often track biologics and therapeutic modality trends.

If you want, I can also narrow this down by:

  1. best for technical antibody/protein science,
  2. best for industry/business trend coverage, or
  3. best for manufacturing/process development.

Observation history

Unlock observation history

Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.